IFNA2 and gastrointestinal stromal tumor: Besides, in vitro and in vivo studies of GIST showed that imatinib, by blocking KIT signaling in DCs, prompted DC-mediated NK cell activation, and stimulated the production of IFNα from NK cells [86].